| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/27/2011 | US20110021537 Heterocyclic pyrazole-carboxamidesas p2y12 antagonists |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021492 Pyridazine derivatives as factor xia inhibitors |
| 01/27/2011 | US20110021489 Substituted piperidines |
| 01/27/2011 | US20110021430 Modified vitamin k-dependent polypeptides |
| 01/27/2011 | US20110021418 Enriched haptoglobin polymers for the treatment of disease |
| 01/27/2011 | US20110021355 Formulation with reduced hygroscopicity |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020471 Erythrocyte atp-release modulators |
| 01/27/2011 | US20110020455 Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020349 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020298 Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020274 Mobilization of hematopoietic stem cells |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | DE102009034131A1 Composition, useful e.g. as volume substitute, and for prophylaxis and therapy of reperfusion syndrome and hypovolemia, comprises an aqueous composition of inosine and a hydrocolloid including hydroxyethyl starch, gelatin and/or albumin |
| 01/27/2011 | CA2769133A1 Cell protection in dialysis patients by administration of a creatine compound |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 01/26/2011 | EP2277874A1 Activator for peroxisome proliferator-activated receptor |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2276342A1 Substituted tetracycline compounds |
| 01/26/2011 | EP1849795B1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 01/26/2011 | EP1615612B1 Pro-urokinase mutant for lysis of occlusive blood clots while sparing wound sealing clots in the treatment of stroke |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | CN1775284B Blood-viscosity reducing agent |
| 01/26/2011 | CN101955505A Novel immune suppressor and composition thereof |
| 01/26/2011 | CN101954051A Traditional Chinese medicinal composite used for curing cerebral thrombosis |
| 01/26/2011 | CN101954007A Couchgrass root product and preparation method thereof |
| 01/26/2011 | CN101953997A Traditional Chinese medicine capable of nourishing yin, strengthening yang, supplementing qi and nourishing blood |
| 01/26/2011 | CN101953994A Chinese medicament for treating luekopenia after concurrent chemoradiotherapy |
| 01/26/2011 | CN101953986A Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency |
| 01/26/2011 | CN101953976A Preparation method of medicine composition for clearing heat, promoting diuresis and treating stranguria |
| 01/26/2011 | CN101953945A Deer fetus cream and production process thereof |
| 01/26/2011 | CN101953943A Traditional Chinese medicine for treating chronic aplastic anemia |
| 01/26/2011 | CN101953940A Traditional Chinese medicine having function of tonifying kidney, invigorating blood circulation and relieving pain, preparation method and quality specification thereof |
| 01/26/2011 | CN101953936A Traditional Chinese medicine preparation for treating immune thrombocytopenia and preparation method thereof |
| 01/26/2011 | CN101953918A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/26/2011 | CN101953912A Rose donkey-hide gelatin jelly and preparation method thereof |
| 01/26/2011 | CN101953852A Antithrombin preparation and preparation method thereof |
| 01/26/2011 | CN101953841A Swine eperythrozoonosis-resisting compound long-acting oxytetracycline injection and preparation method thereof |
| 01/26/2011 | CN101953812A Lansoprazole enteric coated tablet and preparation method thereof |
| 01/26/2011 | CN101953810A Breviscapine pill |
| 01/26/2011 | CN101953783A Preparation process of troxerutin injection |
| 01/26/2011 | CN101618161B Traditional Chinese medicine composition for treating thrombophlebitis and preparation method thereof |
| 01/26/2011 | CN101559039B Method for producing nattokinase liposome from phytosterol |
| 01/26/2011 | CN101496787B Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
| 01/26/2011 | CN101485886B Blood platelet additive solution and preparation method thereof |
| 01/26/2011 | CN101433581B Pharmaceutical composition and its uses |
| 01/26/2011 | CN101416991B Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| 01/26/2011 | CN101411730B Use of oak extract in preparing medicament for treating epidermis injury of person |
| 01/26/2011 | CN101401905B Chinese medicinal composition for treating aplastic anemia |
| 01/26/2011 | CN101172997B Oligopeptide or its modified compound/derivant and application thereof |
| 01/26/2011 | CN101081229B Plasma subtitute injection using hydroxyethyl group amylum as blood plasma dilatancy agent |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875592 Sulfated oligosaccharide derivatives |
| 01/25/2011 | US7875301 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2599158C Pharmaceutical agent comprising solifenacin |
| 01/25/2011 | CA2477557C Stabilized albumin preparations |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2363053C Clopidogrel bisulfate tablet formulation |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/20/2011 | WO2011008885A1 Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same |
| 01/20/2011 | WO2011007856A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer |
| 01/20/2011 | WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/20/2011 | WO2011006355A1 Compounds as hypoxia mimetics, and compositions, and uses thereof |
| 01/20/2011 | US20110015586 Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015241 Substituted heterocycles and use thereof |
| 01/20/2011 | US20110015223 Compounds and methods for treatment of cancer-related anemia |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015168 Methods for increasing levels of human fetal hemoglobin |
| 01/20/2011 | US20110015159 Methods of inhibiting vascular permeability and apoptosis |
| 01/20/2011 | US20110015150 Methods of administering compositions including iron |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110015128 Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same |
| 01/20/2011 | US20110014290 System and method for facilitating hemostasis with an absorbable sponge |
| 01/20/2011 | US20110014179 Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) in a selected subpopulation of ich patients |
| 01/20/2011 | US20110014173 Axl tyrosine kinase inhibitors and methods of making and using the same |
| 01/20/2011 | US20110014170 Novel alpha-galactosidases |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014159 Method for obtaining characterized muscle-derived cell populations and uses |
| 01/20/2011 | US20110014137 Methods for protecting the skin from radiation insults |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | CA2768505A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer |
| 01/20/2011 | CA2767911A1 Compounds as hypoxia mimetics, and compositions, and uses thereof |